CYP2D6 Pharmacogenetics in Nigerian Sickle Cell Disease: Phase 1 of Implementing Pharmacogenomics Testing for Effective Care and Treatment in Africa (iPROTECTA) program
2025Gates Open ResearchJournalOpen access
10.12688/gatesopenres.16370.1Full text2 citations